LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing syste… Read more
LivaNova PLC (LIVN) - Total Assets
Latest total assets as of September 2025: $2.56 Billion USD
Based on the latest financial reports, LivaNova PLC (LIVN) holds total assets worth $2.56 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
LivaNova PLC - Total Assets Trend (1992–2024)
This chart illustrates how LivaNova PLC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
LivaNova PLC - Asset Composition Analysis
Current Asset Composition (December 2024)
LivaNova PLC's total assets of $2.56 Billion consist of 45.0% current assets and 55.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.1% |
| Accounts Receivable | $223.70 Million | 8.9% |
| Inventory | $147.57 Million | 5.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $237.29 Million | 9.5% |
| Goodwill | $750.01 Million | 29.9% |
Asset Composition Trend (1992–2024)
This chart illustrates how LivaNova PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LivaNova PLC's current assets represent 45.0% of total assets in 2024, a decrease from 84.9% in 1992.
- Cash Position: Cash and equivalents constituted 17.1% of total assets in 2024, down from 33.3% in 1992.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 0.0% in 1992.
- Asset Diversification: The largest asset category is goodwill at 29.9% of total assets.
LivaNova PLC Competitors by Total Assets
Key competitors of LivaNova PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
LivaNova PLC - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - LivaNova PLC generates 0.50x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, LivaNova PLC generates $ 2.52 in net profit.
LivaNova PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.33 | 3.37 | 2.29 |
| Quick Ratio | 1.12 | 2.87 | 1.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $269.56 Million | $ 768.71 Million | $ 398.99 Million |
LivaNova PLC - Advanced Valuation Insights
This section examines the relationship between LivaNova PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.11 |
| Latest Market Cap to Assets Ratio | 1.27 |
| Asset Growth Rate (YoY) | 3.2% |
| Total Assets | $2.51 Billion |
| Market Capitalization | $3.18 Billion USD |
Valuation Analysis
Above Book Valuation: The market values LivaNova PLC's assets above their book value (1.27 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: LivaNova PLC's assets grew by 3.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for LivaNova PLC (1992–2024)
The table below shows the annual total assets of LivaNova PLC from 1992 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.51 Billion | +3.16% |
| 2023-12-31 | $2.43 Billion | +5.87% |
| 2022-12-31 | $2.29 Billion | +4.26% |
| 2021-12-31 | $2.20 Billion | -8.29% |
| 2020-12-31 | $2.40 Billion | -0.49% |
| 2019-12-31 | $2.41 Billion | -5.41% |
| 2018-12-31 | $2.55 Billion | +1.83% |
| 2017-12-31 | $2.50 Billion | +6.89% |
| 2016-12-31 | $2.34 Billion | -8.45% |
| 2015-12-31 | $2.56 Billion | +769.75% |
| 2014-12-31 | $294.19 Million | 0.00% |
| 2013-12-31 | $294.19 Million | +11.42% |
| 2012-12-31 | $264.04 Million | +24.60% |
| 2011-12-31 | $211.91 Million | +0.21% |
| 2010-12-31 | $211.47 Million | +1.93% |
| 2009-12-31 | $207.47 Million | +41.89% |
| 2008-12-31 | $146.21 Million | +39.00% |
| 2007-12-31 | $105.19 Million | -22.79% |
| 2006-12-31 | $136.23 Million | -10.55% |
| 2005-12-31 | $152.30 Million | +54.06% |
| 2004-12-31 | $98.86 Million | +4.83% |
| 2003-12-31 | $94.30 Million | -0.84% |
| 2002-12-31 | $95.10 Million | +36.06% |
| 2001-12-31 | $69.90 Million | +2.80% |
| 2000-12-31 | $67.99 Million | +69.98% |
| 1999-12-31 | $40.00 Million | +0.50% |
| 1998-12-31 | $39.80 Million | -5.46% |
| 1997-12-31 | $42.10 Million | -19.96% |
| 1996-12-31 | $52.60 Million | +1248.72% |
| 1995-12-31 | $3.90 Million | -60.20% |
| 1994-12-31 | $9.80 Million | -50.51% |
| 1993-12-31 | $19.80 Million | -21.43% |
| 1992-12-31 | $25.20 Million | -- |